IREN Outlines $25B-$30B AI Capex Plan; Funding Bridge Remains Key Risk
Read source articleWhat happened
IREN disclosed plans for $25B-$30B in capital expenditures to expand its AI cloud infrastructure, building on its existing contracted backlog and GPU pipeline. The company currently holds $14B in committed funding, but the plan will require additional GPU financing and customer prepayments to close the gap. This accelerates the capital intensity already flagged in our latest report, where FY2026 saw $1.48B in quarterly investing outflows and a net loss of $(702.6)M. Meanwhile, shares outstanding have risen from 258.1M to 356.9M over the past year, highlighting dilution risk if equity is used. The key question remains whether customer acceptance and recognized AI revenue can scale fast enough to justify the spending without further balance-sheet strain.
Implication
Investors should treat the capex announcement as a stress test for IREN's funding model rather than a pure growth signal. While $14B of current funding covers near-term needs, the $25B-$30B total implies significant additional financing requirements, and the recent history of dilution and large impairments suggests the market may not reward equity-funded expansion. Positive catalysts include Microsoft tranche acceptances and a quarterly AI revenue step-up above $33.6M, which would validate the transition. Conversely, any delays in Horizons 2-4 or weaker prepayment terms would undermine the thesis and push fair value toward the bear-case $28. We maintain our WAIT rating with an attractive entry around $32 and trim above $56, and we would downgrade if new equity issuance exceeds 5% by March 2027 without corresponding revenue conversion.
Thesis delta
The capex plan is larger than previously modeled, increasing the funding burden and dilution risk. However, the company's existing liquidity and customer prepayment benchmarks provide some offset, so the core thesis remains contingent on execution rather than capital availability alone. Overall, the risk-reward skews slightly more negative, but no change in rating yet.
Confidence
Medium